The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Smith Andrew P since 2015.
The trader's CIK number is 1632778.
At the time of the last reporting, Smith Andrew P was the Chief Financial Officer of Sucampo Pharmaceuticals, Inc.. (stock ticker symbol SCMP).
Also see all insider trading activities at Sucampo Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | SCMP | 0 | $0 | 1,766 | $27,514 | 0 | $0 |
| 2015 | SCMP | 1,605 | $27,333 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-15 | SCMP | Sale | 1,766 | 15.58 | 27,514 |
| 2015-11-16 | SCMP | Buy | 1,605 | 17.03 | 27,333 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Andrew P (Chief Financial Officer of Sucampo Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.